Reuters logo
4 years ago
Orion profit falls as Parkinson's drug patents expire
April 23, 2013 / 9:16 AM / 4 years ago

Orion profit falls as Parkinson's drug patents expire

1 Min Read

HELSINKI, April 23 (Reuters) - Finnish drug maker Orion reported a fall in first-quarter profit, in line with expectations, due to the expiration of its patents for Parkinson's drugs.

Orion's quarterly operating profit fell 6 percent from a year earlier to 74 million euros ($96 million), matching the average forecast of analysts in a Reuters poll.

The company repeated it expects a slight fall in full-year 2013 operating profit, and shares in the company fell 0.8 percent to 20.20 euros. ($1 = 0.7674 euros) (Reporting By Jussi Rosendahl)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below